Developer docs
API playgroundTry for free, no card

Search company profiles

Artemis Growth Partners

Full company profile

uuid000efqu

Namestring
Artemis Growth Partners
Legal namestring
Artemis Growth Partners LLC
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Artemis Growth Partners is a privately held investment and advisory firm founded in 2015 that manages US $300+ million in mission-driven, discretionary assets under management dedicated to the global cannabis industry. The firm positions itself as the first ESG and impact-focused fund in cannabis, deploying capital across four investment themes — Branded Product, Distribution and Commerce, Genetics, and Technology — and across the full cannabis value chain including licensed operators, branded product companies, distributors, ancillary service providers, and science-driven R&D platforms. Its portfolio spans 30+ companies headquartered in North America, Europe, Latin America, the Caribbean, the Middle East, and Asia, with notable holdings including Green Thumb Industries (GTII.CN), Clever Leaves (NASDAQ:CLVR), Kiva Confections, PAX Labs, and Nabis.

The firm generates revenue through conventional private fund economics — ongoing management fees calculated as a percentage of AUM, supplemented by carried interest on profitable exits. Its general partnership is led by founder William Muecke (Co-Founder and Managing Member) and a small team (1-10 employees) drawn from senior ranks at Goldman Sachs, JPMorgan, and Mesoamerica, supplemented by direct operating experience running licensed cannabis businesses. The firm maintains headquarters in London and a regional office in Santa Ana, Costa Rica, and serves two customer sets: cannabis entrepreneurs seeking growth capital and strategic guidance, and institutional or high-net-worth investors seeking ESG-aligned exposure to the sector.

Operationally, Artemis pursues proprietary deal flow through direct relationships, industry events, and an investor portal/virtual data room for LPs, with no public pricing or fund terms disclosed. Notable realized exits between 2019 and 2021 include Lord Jones (acquired by Cronos), Acreage Holdings (acquired by Canopy Growth), Solo Sciences (acquired by KERN), Caliva (sold to Subversive Capital), and High 12 Brands (acquired by Materia), providing both return realization and validation of its multi-thematic investment strategy.

Short descriptiontext

Artemis Growth Partners is a private ESG and impact-focused investment firm managing US $300+ million in discretionary AUM across the global cannabis value chain, deploying capital to branded product, distribution, genetics, and technology companies worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSanta Ana, Costa Rica
HQ citystring
Santa Ana
HQ countrystring
Costa Rica
HQ regionstring
Latin America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis investment management, ESG impact investing, private equity funds, venture capital services, asset management advisory
Industry1 code
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • All Other Financial Investment Activities52399
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Cannabis Investment Management
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Asset Management Fees
TypeManaged Services
Description

Artemis Growth Partners generates revenue through management fees on their US $300+ million in mission-driven discretionary assets under management (AUM). As a fund manager, they likely earn ongoing management fees calculated as a percentage of AUM.

artemisgrowth.com
2Carried Interest / Performance Fees
TypeLicensing Royalties
Description

As professional investors who develop, structure, manage, and exit successful investments in emerging industries, the firm earns carried interest on profitable exits of portfolio companies.

artemisgrowth.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Artemis Growth Partners is a private investment firm that deploys capital into the global cannabis value chain, managing US $300+ million in mission-driven discretionary assets under management (AUM). The firm invests across four themes — Branded Product, Distribution and Commerce, Genetics, and Technology — and serves as both a capital partner for cannabis entrepreneurs and a fiduciary for cannabis investors. Revenue is generated through asset management fees on AUM and carried interest on successful portfolio exits.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Artemis Growth Partners is an ESG and impact-focused investment firm in the global cannabis industry, not a technology product company. The firm manages US $300+ million in mission-driven assets under management and invests across four main themes: Branded Product, Distribution and Commerce, Genetics, and Technology. They provide investment capital and expertise to cannabis entrepreneurs rather than offering a software product or platform.

Product and service5 records
1Artemis Cannabis Investment Fund (ESG & Impact Mandate)
CategoryInvestment Fund Management
Description

Discretionary pooled investment vehicle deploying capital across the global cannabis value chain under an ESG and impact mandate. Targets operators in branded products, distribution, ancillary services, and science-driven R&D platforms across North America, Europe, Israel, and equatorial cultivation regions. Revenue is generated via management fees on AUM and carried interest on successful exits. Designed for institutional and high-net-worth investors seeking professionally managed cannabis exposure.

2Branded Product Investment Theme
CategoryInvestment Theme — Branded Product
Description

Investment allocation focused on consumer and patient connection, brand identity, and relationship with consumers in the cannabis industry. Portfolio examples include Kiva Confections, Lord Jones, and Caliva. Designed for cannabis entrepreneurs seeking capital to scale branded cannabis product companies.

3Distribution and Commerce Investment Theme
CategoryInvestment Theme — Distribution and Commerce
Description

Investment allocation focused on supply chain control and defensible distribution plays in the cannabis value chain. Portfolio examples include Green Thumb Industries (GTII), 4Front, Nabis, Leaf Trade, and Flower Company. Targets licensed cannabis businesses seeking capital to expand distribution infrastructure and commerce platforms.

4Genetics Investment Theme
CategoryInvestment Theme — Genetics
Description

Investment allocation focused on plant breeding, genetic discovery, cannabinoid expression, and micropropagation in cannabis cultivation. Portfolio examples include Phylos Bioscience and Conception Nurseries. Supports science-driven R&D platforms and cultivators seeking to improve plant quality and efficacy through genetic innovation.

5Technology Investment Theme
CategoryInvestment Theme — Technology
Description

Investment allocation focused on new distribution methods, consumer and provider applications, and disruptive online markets for the cannabis industry. Portfolio examples include PAX Labs, Jane Technologies (iHeartJane), Leaf Trade, Solo Sciences, iCAN, and Prohibition Partners. Backs technology and service providers enabling compliant, scalable cannabis commerce.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership34 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - a national cannabis consumer packaged goods company and retailer dedicated to providing dignified access to cannabis. GTI manufactures and distributes branded cannabis products including Rythm, Dogwalkers, The Feel Collection, and Beboe. The company operates Rise and Essence retail stores across 12 U.S. markets with 13 manufacturing facilities and 89 retail locations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - maker of hand-crafted CBD-infused chocolate products using single origin Ecuadorian dark chocolate and full-spectrum phytocannabinoid-rich CBD extract. Acquired by Cronos (NASDAQ:CRON).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - one of the largest and fastest-growing edible products companies in the cannabis industry with enviable market leadership throughout its multi-state footprint. Known for world-class operations with focus on efficacy, food safety, and business integrity.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - fully-licensed Colombian operator and subsidiary of Northern Swan, on track to be the world's largest low-cost provider of medical cannabis. Operates over 10 million ft2 of growable terrain with the largest pharmaceutical grade extraction plant and GMP-certified processing facilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - leading retail and brand development company with 4 vertically-integrated licenses in limited license states. Operates retail business under the Mission brand name. Publicly traded under FFNT.CN on Canadian Securities Exchange.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - one of the largest medical cannabis companies operating in highly regulated U.S. states with a mission to improve the quality of life for patients in need of cannabis-related medicine.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - leading vertically-integrated multi-state operator in 14 legal U.S. states serving adult-use consumers and medical patients. Acquired by Canopy Growth. Publicly traded under ACRG.U on the Canadian Securities Exchange.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - leading vertically-integrated multi-state operator in 10 legal U.S. states, Washington D.C., and Puerto Rico. Merged with Canaccord Genuity Growth Corp SPAC to be publicly traded under CCHW.NE on NEO (Canada).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - vertically-integrated cannabis consumer products company headquartered in Buellton, CA. Dedicated to making cannabis a modern agricultural crop with precision agriculture and biotechnology, cultivating at lowest production cost.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - leading vertically-integrated California brand in cultivation, wholesale, distribution, and branded product. Sold to Subversive Capital (NEO:GRAM.U).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - premium sun-grown, small batch sustainable cannabis from California's Emerald Triangle cultivators. Devoted to providing highest quality cannabis supply chain management benefiting consumers, growers, and environment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - pioneering global medical cannabis company harnessing nature's medicine. World leader in outdoor cultivation of medical cannabis at 4.4 million square foot farm in St Ann, Jamaica. First company to export Jamaican medical cannabis flower internationally.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - award-winning consumer technology brand and gold standard for cannabis devices. Delivers best-in-class software and hardware for personalized consumer experience. Lead investors include Tiger Global and Tao Capital Partners (Pritzker family).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - California-based agriculture-technology company providing clean, genetically certified cannabis clones using tissue culture micropropagation. Solves cultivators' problems by bringing proven agricultural technology to cannabis.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - wholesale cannabis delivery operating as 'The Costco of Cannabis'. Club approach cuts supply chain overhead to deliver low-cost, high quality cannabis to patients and consumers across California.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - provides closed-loop trade and tracking system using unique identifier printed tags instead of high-cost RFID technology. Provides greater security, tracking, compliance, and consumer-oriented solutions. Acquired by KERN:NASDAQ.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - CBD brand philosophy offering high quality, innovative hemp-derived products from 100% organic Colorado-grown plants. Products include full spectrum oils and capsules with 0% THC isolate.

18iCAN
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - manages leading world events platforms for global cannabis (CannaTech summits), provides research and consulting services (iCAN Serve), and operates incubator platform (iCAN Incubate) for cannabis development in Israel.

artemisgrowth.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - complete outsourcing solution for manufacturing of medicinal cannabis extracts using sophisticated supercritical CO2 extraction technology. Contract manufacturing from product formulations to packaging.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - cannabis-infused social tonic crafted in California. Uses all-natural ingredients to create light, refreshing social buzz. Available in dispensaries across California, Illinois, Massachusetts, Nevada, and Rhode Island.

21Asia Horizon Group
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - holding company building licensed producer headquartered in Asia with global reach. First western-backed company awarded license by Chinese government to process cannabinoids from hemp.

artemisgrowth.com
22High 12
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - cannabis-focused Consumer Packaged Goods company building and operating premier global cannabis brands. Acquired by Materia.

artemisgrowth.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - cannabis social entrepreneurs led by CJ Wallace (son of The Notorious B.I.G.), encouraging global community to embrace curiosity and creativity. Focus on using cannabis to empower, heal, and inspire.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - genomics company on a mission to better understand cannabis. Launched 95,000 SQFT plant breeding campus near Portland for R&D. Operating data-driven breeding program and helped launch Conception Nurseries.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - medical cannabis company operating in Colombia with state-of-the-art organic agricultural technology and innovative pharmaceutical processes. Publicly traded under MCCN.CN.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - global leader in cannabis data, media, and conferences. Delivers knowledge, insight, and network fundamental to the cannabis industry through portfolio of wholly owned companies.

27CBVIT
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - leading cannabis (hemp) specialists creating premium CBD health and beauty products. Born in Czech Republic with over 12 years producing hemp goods. Pharmaceutical grade production facility with CO2 extraction.

artemisgrowth.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - develops and manufactures premium plant-based products including hemp-based CBD oils, skincare, body care, hair care, and pet products. 20+ years of experience in natural beauty and food supplements manufacturing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - created iheartjane.com, the cannabis industry's only complete online marketplace. Provides consumers with confident, safe, and simple shopping experience to browse local products, compare prices, and place orders at local stores for free.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - leading distributor of cannabis products servicing hundreds of licensed businesses in California. Distributes 80 brands to more than 750 dispensaries covering 99% of licensed retailers in the state. Proprietary software for compliant order scheduling and tracking.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - dominant wholesale technology platform in Sweet 16 limited license states. Leading wholesale marketplace for cannabis with majority share in fastest growing U.S. states. Partnered with 85+ facilities and 600+ dispensaries in 16 markets.

32Rainbow Cannabis Brands (Kaya, Peace and Skin)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - #1 hemp-based brand portfolio in France aiming to be #1 brand in Europe. Operates Kaya (food supplements) and Peace and Skin (cosmetics) using natural adaptogenic plants along with CBD.

artemisgrowth.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company - leading cannabis importer and prescriber for medical cannabis in Poland and Czech Republic. Provides highest quality flower and concentrates in THC medicinals plus medical-grade and consumer CBD products.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Portfolio company - fully integrated cannabis universe of distinct brands covering wholesale to D2C, flowers to accessories, medical use to lifestyle consumption. Operates Europe's leading telemedicine platform and intuitive product shopping journey.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pioneering cannabis-focused private equity firm investing across the cannabis value chain (brands, technology, distribution). Direct comparable as an early-mover, multi-strategy cannabis PE firm with a similar thematic mandate to Artemis.

TypeDirect peer
Description

Cannabis-specialist growth equity firm that has raised multiple cannabis-focused funds. Directly comparable to Artemis as a sector-specific PE manager deploying capital into emerging cannabis companies globally.

TypeDirect peer
Description

Cannabis-focused venture capital fund investing across the cannabis industry from seed to growth stages. Directly comparable to Artemis as a thematic cannabis investment firm targeting entrepreneurs across the value chain.

TypeDirect peer
Description

Cannabis-focused fund manager offering diversified public/private cannabis exposure. Directly comparable to Artemis in sector specialization, fund management approach, and ESG-conscious positioning.

TypeDirect peer
Description

Cannabis-focused private equity firm investing across plant-touching, brands, ancillary services, and technology. Directly comparable as another multi-fund cannabis PE manager with overlapping investment themes to Artemis.

TypeEmerging player
Description

Cannabis-focused investment firm deploying capital across the global cannabis industry. Comparable to Artemis as a fellow cannabis-specialist investor, though typically operating at a smaller scale.

TypeEmerging player
Description

Cannabis-focused investment network and fund manager connecting investors with cannabis opportunities. Adjacent peer to Artemis given overlapping sector focus, though differentiates on research/events versus direct GP capital.

TypeEmerging player
Description

Cannabinoid-focused biotechnology investment platform investing in companies producing rare cannabinoids. Comparable to Artemis as another sector-specific institutional cannabis investment firm with scientific/R&D orientation.

TypeEmerging player
Description

Cannabis-focused venture capital fund investing in seed and early-stage cannabis companies. Comparable as a thematic cannabis investor, though focused earlier-stage than Artemis.

TypeBroad incumbent
Description

Although primarily an operator, Canopy Growth's acquisition of Acreage and other PE-style stakes places it adjacent. Comparable to Artemis's broader cannabis investment ecosystem, though Canopy is a vertically integrated operator rather than pure PE manager.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment6 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Artemis Growth Partners

Cannabis Investment Managementartemisgrowth.com

Artemis Growth Partners is a private ESG and impact-focused investment firm managing US $300+ million in discretionary AUM across the global cannabis value chain, deploying capital to branded product, distribution, genetics, and technology companies worldwide.

What Artemis Growth Partners does

Artemis Growth Partners is a privately held investment and advisory firm founded in 2015 that manages US $300+ million in mission-driven, discretionary assets under management dedicated to the global cannabis industry. The firm positions itself as the first ESG and impact-focused fund in cannabis, deploying capital across four investment themes — Branded Product, Distribution and Commerce, Genetics, and Technology — and across the full cannabis value chain including licensed operators, branded product companies, distributors, ancillary service providers, and science-driven R&D platforms. Its portfolio spans 30+ companies headquartered in North America, Europe, Latin America, the Caribbean, the Middle East, and Asia, with notable holdings including Green Thumb Industries (GTII.CN), Clever Leaves (NASDAQ:CLVR), Kiva Confections, PAX Labs, and Nabis.

The firm generates revenue through conventional private fund economics — ongoing management fees calculated as a percentage of AUM, supplemented by carried interest on profitable exits. Its general partnership is led by founder William Muecke (Co-Founder and Managing Member) and a small team (1-10 employees) drawn from senior ranks at Goldman Sachs, JPMorgan, and Mesoamerica, supplemented by direct operating experience running licensed cannabis businesses. The firm maintains headquarters in London and a regional office in Santa Ana, Costa Rica, and serves two customer sets: cannabis entrepreneurs seeking growth capital and strategic guidance, and institutional or high-net-worth investors seeking ESG-aligned exposure to the sector.

Operationally, Artemis pursues proprietary deal flow through direct relationships, industry events, and an investor portal/virtual data room for LPs, with no public pricing or fund terms disclosed. Notable realized exits between 2019 and 2021 include Lord Jones (acquired by Cronos), Acreage Holdings (acquired by Canopy Growth), Solo Sciences (acquired by KERN), Caliva (sold to Subversive Capital), and High 12 Brands (acquired by Materia), providing both return realization and validation of its multi-thematic investment strategy.

Artemis Growth Partners firmographics

Firmographics
Name
Artemis Growth Partners
Legal name
Artemis Growth Partners LLC
Website
https://artemisgrowth.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Artemis Growth Partners is a private ESG and impact-focused investment firm managing US $300+ million in discretionary AUM across the global cannabis value chain, deploying capital to branded product, distribution, genetics, and technology companies worldwide.
Ownership category
akta.pro rank

Artemis Growth Partners industry classification

Industry
Product category
Cannabis Investment Management
NAICS
Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity

Keywords

  • Cannabis investment management
  • ESG impact investing
  • Private equity funds
  • Venture capital services
  • Asset management advisory

Where Artemis Growth Partners is headquartered

Location

Headquarters

HQ city
Santa Ana
HQ country
Costa Rica
HQ region
Latin America

Offices2 records

Markets served

Artemis Growth Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Asset Management Fees: Artemis Growth Partners generates revenue through management fees on their US $300+ million in mission-driven discretionary assets under management (AUM). As a fund manager, they likely earn ongoing management fees calculated as a percentage of AUM.
  2. Carried Interest / Performance Fees: As professional investors who develop, structure, manage, and exit successful investments in emerging industries, the firm earns carried interest on profitable exits of portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Artemis Growth Partners product offering

Product offering

Core offering

Artemis Growth Partners is a private investment firm that deploys capital into the global cannabis value chain, managing US $300+ million in mission-driven discretionary assets under management (AUM). The firm invests across four themes — Branded Product, Distribution and Commerce, Genetics, and Technology — and serves as both a capital partner for cannabis entrepreneurs and a fiduciary for cannabis investors. Revenue is generated through asset management fees on AUM and carried interest on successful portfolio exits.

Product overview

Artemis Growth Partners is an ESG and impact-focused investment firm in the global cannabis industry, not a technology product company. The firm manages US $300+ million in mission-driven assets under management and invests across four main themes: Branded Product, Distribution and Commerce, Genetics, and Technology. They provide investment capital and expertise to cannabis entrepreneurs rather than offering a software product or platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • Artemis Cannabis Investment Fund (ESG & Impact Mandate) Discretionary pooled investment vehicle deploying capital across the global cannabis value chain under an ESG and impact mandate. Targets operators in branded products, distribution, ancillary services, and science-driven R&D platforms across North America, Europe, Israel, and equatorial cultivation regions. Revenue is generated via management fees on AUM and carried interest on successful exits. Designed for institutional and high-net-worth investors seeking professionally managed cannabis exposure.
  • Branded Product Investment Theme Investment allocation focused on consumer and patient connection, brand identity, and relationship with consumers in the cannabis industry. Portfolio examples include Kiva Confections, Lord Jones, and Caliva. Designed for cannabis entrepreneurs seeking capital to scale branded cannabis product companies.
  • Distribution and Commerce Investment Theme Investment allocation focused on supply chain control and defensible distribution plays in the cannabis value chain. Portfolio examples include Green Thumb Industries (GTII), 4Front, Nabis, Leaf Trade, and Flower Company. Targets licensed cannabis businesses seeking capital to expand distribution infrastructure and commerce platforms.
  • Genetics Investment Theme Investment allocation focused on plant breeding, genetic discovery, cannabinoid expression, and micropropagation in cannabis cultivation. Portfolio examples include Phylos Bioscience and Conception Nurseries. Supports science-driven R&D platforms and cultivators seeking to improve plant quality and efficacy through genetic innovation.
  • Technology Investment Theme Investment allocation focused on new distribution methods, consumer and provider applications, and disruptive online markets for the cannabis industry. Portfolio examples include PAX Labs, Jane Technologies (iHeartJane), Leaf Trade, Solo Sciences, iCAN, and Prohibition Partners. Backs technology and service providers enabling compliant, scalable cannabis commerce.

Companies that use Artemis Growth Partners

Customer profile

Segments2 records

Ideal customer profiles2 records

Artemis Growth Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Artemis Growth Partners partnerships and signals

Strategic signal

Partnerships

34 partnerships are on record, tiered core and minor.

  • Green Thumb Industries (GTII)coreStrategic or Co-development PartnerPortfolio company - a national cannabis consumer packaged goods company and retailer dedicated to providing dignified access to cannabis. GTI manufactures and distributes branded cannabis products including Rythm, Dogwalkers, The Feel Collection, and Beboe. The company operates Rise and Essence retail stores across 12 U.S. markets with 13 manufacturing facilities and 89 retail locations.
  • Lord JonesminorStrategic or Co-development PartnerPortfolio company - maker of hand-crafted CBD-infused chocolate products using single origin Ecuadorian dark chocolate and full-spectrum phytocannabinoid-rich CBD extract. Acquired by Cronos (NASDAQ:CRON).
  • Kiva ConfectionscoreStrategic or Co-development PartnerPortfolio company - one of the largest and fastest-growing edible products companies in the cannabis industry with enviable market leadership throughout its multi-state footprint. Known for world-class operations with focus on efficacy, food safety, and business integrity.
  • Clever LeavescoreStrategic or Co-development PartnerPortfolio company - fully-licensed Colombian operator and subsidiary of Northern Swan, on track to be the world's largest low-cost provider of medical cannabis. Operates over 10 million ft2 of growable terrain with the largest pharmaceutical grade extraction plant and GMP-certified processing facilities.
  • 4FrontminorStrategic or Co-development PartnerPortfolio company - leading retail and brand development company with 4 vertically-integrated licenses in limited license states. Operates retail business under the Mission brand name. Publicly traded under FFNT.CN on Canadian Securities Exchange.
  • PharmacannminorStrategic or Co-development PartnerPortfolio company - one of the largest medical cannabis companies operating in highly regulated U.S. states with a mission to improve the quality of life for patients in need of cannabis-related medicine.
  • Acreage HoldingsminorStrategic or Co-development PartnerPortfolio company - leading vertically-integrated multi-state operator in 14 legal U.S. states serving adult-use consumers and medical patients. Acquired by Canopy Growth. Publicly traded under ACRG.U on the Canadian Securities Exchange.
  • Columbia Care (CCHW)minorStrategic or Co-development PartnerPortfolio company - leading vertically-integrated multi-state operator in 10 legal U.S. states, Washington D.C., and Puerto Rico. Merged with Canaccord Genuity Growth Corp SPAC to be publicly traded under CCHW.NE on NEO (Canada).
  • Central Coast Agriculture (Raw Garden)minorStrategic or Co-development PartnerPortfolio company - vertically-integrated cannabis consumer products company headquartered in Buellton, CA. Dedicated to making cannabis a modern agricultural crop with precision agriculture and biotechnology, cultivating at lowest production cost.
  • CalivaminorStrategic or Co-development PartnerPortfolio company - leading vertically-integrated California brand in cultivation, wholesale, distribution, and branded product. Sold to Subversive Capital (NEO:GRAM.U).
  • Flow KanaminorStrategic or Co-development PartnerPortfolio company - premium sun-grown, small batch sustainable cannabis from California's Emerald Triangle cultivators. Devoted to providing highest quality cannabis supply chain management benefiting consumers, growers, and environment.
  • JacanacoreStrategic or Co-development PartnerPortfolio company - pioneering global medical cannabis company harnessing nature's medicine. World leader in outdoor cultivation of medical cannabis at 4.4 million square foot farm in St Ann, Jamaica. First company to export Jamaican medical cannabis flower internationally.
  • PAX LabscoreStrategic or Co-development PartnerPortfolio company - award-winning consumer technology brand and gold standard for cannabis devices. Delivers best-in-class software and hardware for personalized consumer experience. Lead investors include Tiger Global and Tao Capital Partners (Pritzker family).
  • Conception NurseriesminorStrategic or Co-development PartnerPortfolio company - California-based agriculture-technology company providing clean, genetically certified cannabis clones using tissue culture micropropagation. Solves cultivators' problems by bringing proven agricultural technology to cannabis.
  • Flower CompanyminorStrategic or Co-development PartnerPortfolio company - wholesale cannabis delivery operating as 'The Costco of Cannabis'. Club approach cuts supply chain overhead to deliver low-cost, high quality cannabis to patients and consumers across California.
  • Solo Sciences Inc.minorStrategic or Co-development PartnerPortfolio company - provides closed-loop trade and tracking system using unique identifier printed tags instead of high-cost RFID technology. Provides greater security, tracking, compliance, and consumer-oriented solutions. Acquired by KERN:NASDAQ.
  • Plant PeopleminorStrategic or Co-development PartnerPortfolio company - CBD brand philosophy offering high quality, innovative hemp-derived products from 100% organic Colorado-grown plants. Products include full spectrum oils and capsules with 0% THC isolate.
  • iCANcoreStrategic or Co-development PartnerPortfolio company - manages leading world events platforms for global cannabis (CannaTech summits), provides research and consulting services (iCAN Serve), and operates incubator platform (iCAN Incubate) for cannabis development in Israel.
  • AureumminorStrategic or Co-development PartnerPortfolio company - complete outsourcing solution for manufacturing of medicinal cannabis extracts using sophisticated supercritical CO2 extraction technology. Contract manufacturing from product formulations to packaging.
  • Cann Social TonicsminorStrategic or Co-development PartnerPortfolio company - cannabis-infused social tonic crafted in California. Uses all-natural ingredients to create light, refreshing social buzz. Available in dispensaries across California, Illinois, Massachusetts, Nevada, and Rhode Island.
  • Asia Horizon GroupcoreStrategic or Co-development PartnerPortfolio company - holding company building licensed producer headquartered in Asia with global reach. First western-backed company awarded license by Chinese government to process cannabinoids from hemp.
  • High 12minorStrategic or Co-development PartnerPortfolio company - cannabis-focused Consumer Packaged Goods company building and operating premier global cannabis brands. Acquired by Materia.
  • Think BIGminorStrategic or Co-development PartnerPortfolio company - cannabis social entrepreneurs led by CJ Wallace (son of The Notorious B.I.G.), encouraging global community to embrace curiosity and creativity. Focus on using cannabis to empower, heal, and inspire.
  • Phylos BiosciencecoreStrategic or Co-development PartnerPortfolio company - genomics company on a mission to better understand cannabis. Launched 95,000 SQFT plant breeding campus near Portland for R&D. Operating data-driven breeding program and helped launch Conception Nurseries.
  • MedcolcannaminorStrategic or Co-development PartnerPortfolio company - medical cannabis company operating in Colombia with state-of-the-art organic agricultural technology and innovative pharmaceutical processes. Publicly traded under MCCN.CN.
  • Prohibition PartnersminorStrategic or Co-development PartnerPortfolio company - global leader in cannabis data, media, and conferences. Delivers knowledge, insight, and network fundamental to the cannabis industry through portfolio of wholly owned companies.
  • CBVITminorStrategic or Co-development PartnerPortfolio company - leading cannabis (hemp) specialists creating premium CBD health and beauty products. Born in Czech Republic with over 12 years producing hemp goods. Pharmaceutical grade production facility with CO2 extraction.
  • PhytoPūr BiominorStrategic or Co-development PartnerPortfolio company - develops and manufactures premium plant-based products including hemp-based CBD oils, skincare, body care, hair care, and pet products. 20+ years of experience in natural beauty and food supplements manufacturing.
  • Jane Technologies (iHeartJane)coreStrategic or Co-development PartnerPortfolio company - created iheartjane.com, the cannabis industry's only complete online marketplace. Provides consumers with confident, safe, and simple shopping experience to browse local products, compare prices, and place orders at local stores for free.
  • NabiscoreStrategic or Co-development PartnerPortfolio company - leading distributor of cannabis products servicing hundreds of licensed businesses in California. Distributes 80 brands to more than 750 dispensaries covering 99% of licensed retailers in the state. Proprietary software for compliant order scheduling and tracking.
  • Leaf TradecoreStrategic or Co-development PartnerPortfolio company - dominant wholesale technology platform in Sweet 16 limited license states. Leading wholesale marketplace for cannabis with majority share in fastest growing U.S. states. Partnered with 85+ facilities and 600+ dispensaries in 16 markets.
  • Rainbow Cannabis Brands (Kaya, Peace and Skin)minorStrategic or Co-development PartnerPortfolio company - #1 hemp-based brand portfolio in France aiming to be #1 brand in Europe. Operates Kaya (food supplements) and Peace and Skin (cosmetics) using natural adaptogenic plants along with CBD.
  • Soteria HoldingsminorStrategic or Co-development PartnerPortfolio company - leading cannabis importer and prescriber for medical cannabis in Poland and Czech Republic. Provides highest quality flower and concentrates in THC medicinals plus medical-grade and consumer CBD products.
  • Bloomwell GroupcoreStrategic or Co-development PartnerPortfolio company - fully integrated cannabis universe of distinct brands covering wholesale to D2C, flowers to accessories, medical use to lifestyle consumption. Operates Europe's leading telemedicine platform and intuitive product shopping journey.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Artemis Growth Partners competitors and assessment

Company assessment

Direct peers

  • Privateer Holdings: Pioneering cannabis-focused private equity firm investing across the cannabis value chain (brands, technology, distribution). Direct comparable as an early-mover, multi-strategy cannabis PE firm with a similar thematic mandate to Artemis.
  • Tuatara Capital: Cannabis-specialist growth equity firm that has raised multiple cannabis-focused funds. Directly comparable to Artemis as a sector-specific PE manager deploying capital into emerging cannabis companies globally.
  • Casa Verde Capital: Cannabis-focused venture capital fund investing across the cannabis industry from seed to growth stages. Directly comparable to Artemis as a thematic cannabis investment firm targeting entrepreneurs across the value chain.
  • Poseidon Asset Management: Cannabis-focused fund manager offering diversified public/private cannabis exposure. Directly comparable to Artemis in sector specialization, fund management approach, and ESG-conscious positioning.
  • Merida Capital Partners: Cannabis-focused private equity firm investing across plant-touching, brands, ancillary services, and technology. Directly comparable as another multi-fund cannabis PE manager with overlapping investment themes to Artemis.

Emerging players

  • Salveo Capital: Cannabis-focused investment firm deploying capital across the global cannabis industry. Comparable to Artemis as a fellow cannabis-specialist investor, though typically operating at a smaller scale.
  • Arcview Group: Cannabis-focused investment network and fund manager connecting investors with cannabis opportunities. Adjacent peer to Artemis given overlapping sector focus, though differentiates on research/events versus direct GP capital.
  • Demetrix (PE platform): Cannabinoid-focused biotechnology investment platform investing in companies producing rare cannabinoids. Comparable to Artemis as another sector-specific institutional cannabis investment firm with scientific/R&D orientation.
  • Entourage Effect Capital: Cannabis-focused venture capital fund investing in seed and early-stage cannabis companies. Comparable as a thematic cannabis investor, though focused earlier-stage than Artemis.

Broad incumbents

  • Canopy Growth (CE) / Constellation Capital: Although primarily an operator, Canopy Growth's acquisition of Acreage and other PE-style stakes places it adjacent. Comparable to Artemis's broader cannabis investment ecosystem, though Canopy is a vertically integrated operator rather than pure PE manager.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Artemis Growth Partners social profiles

Digital presence

Artemis Growth Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Artemis Growth Partners leadership team

Management profile

Number of profiles

Profiles1 record

Artemis Growth Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Artemis Growth Partners M&A and investment

M&A and investment

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artemis Growth Partners

What does Artemis Growth Partners do?

Artemis Growth Partners is a private investment firm that deploys capital into the global cannabis value chain, managing US $300+ million in mission-driven discretionary assets under management (AUM). The firm invests across four themes — Branded Product, Distribution and Commerce, Genetics, and Technology — and serves as both a capital partner for cannabis entrepreneurs and a fiduciary for cannabis investors. Revenue is generated through asset management fees on AUM and carried interest on successful portfolio exits.

Is Artemis Growth Partners a public or private company?

Artemis Growth Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Artemis Growth Partners founded?

Artemis Growth Partners was founded in 2015. It employs 1 to 10 people.

Where is Artemis Growth Partners based?

Artemis Growth Partners is headquartered in Santa Ana, Costa Rica, in the Latin America region.

How does Artemis Growth Partners make money?

Two revenue lines are on record. Asset Management Fees are the primary driver. The others are carried Interest / Performance Fees.

Who are Artemis Growth Partners's main competitors?

Direct peers on record are Privateer Holdings, Tuatara Capital, Casa Verde Capital, Poseidon Asset Management and Merida Capital Partners. Emerging players are Salveo Capital, Arcview Group, Demetrix (PE platform) and Entourage Effect Capital. Canopy Growth (CE) / Constellation Capital is listed as a broad incumbent.

Does Artemis Growth Partners have an API?

No public API is recorded for Artemis Growth Partners.

What industry is Artemis Growth Partners in?

Artemis Growth Partners's product category is Cannabis Investment Management. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireArtemis Growth Partners Appoints James Hayward as Advisory Director Amid Institutional Shift in Global Emergent Medicinal TherapeuticsArtemis Growth Partners appointed James Hayward as Advisory Director, bringing his 35-year JPMorgan credit experience. He will advise on capital formation and LP relationships as the medical cannabis sector matures. The firm manages over $300 million in assets across six vehicles.YahooAurora Cannabis to Speak at the Global Cannabis Regulatory SummitAurora Cannabis will speak at the 2025 Global Cannabis Regulatory Summit in Washington, D.C. on March 26-27, 2025. The company will advocate for policy reform and discuss differences between medical and adult-use cannabis. The summit is hosted by Artemis Growth Partners.PR NewswireAurora Cannabis to Speak at the Global Cannabis Regulatory SummitAurora Cannabis will speak at the 2025 Global Cannabis Regulatory Summit in Washington, D.C., on March 26-27. The company will advocate for policy reform and discuss differences between medical and adult-use cannabis. The summit is hosted by Artemis Growth Partners.Business & FinancialAurora Cannabis To Speak At The Global Cannabis Regulatory SummitAurora Cannabis will speak at the 2025 Global Cannabis Regulatory Summit in Washington, D.C. on March 26-27, 2025. The company will advocate for policy reform and discuss differences between medical and adult-use cannabis. The summit is hosted by Artemis Growth Partners.Grit Daily NewsCannabis Tech Startup Rainbow Raises €2 Million to Expand Operations InternationallyFrench cannabis tech startup Rainbow has raised €2 million from investors including Sensei Ventures and Artemis Growth to expand its operations across Europe. The funding will support expansion into Italy, Germany, and Poland, as well as the launch of new brands and workforce growth, with the company aiming to reach 5 million sales by the end of 2021.PR NewswireLeaf Trade Closes $5.5M Series A Round Led by Artemis Growth Partners, HPAChicago-based Leaf Trade, a cannabis wholesale marketplace and payments platform, closed a $5.5 million Series A preferred round led by Artemis Growth Partners with participation from Hyde Park Angels, bringing total funding to $10 million. The company operates in 17 states and reports over $1 billion in annualized net GMV.GlobalaginvestingArtemis Growth Partners Leads $105M Acquisition of Bridge Farm Group from Sundial GrowersArtemis Growth Partners acquired Bridge Farm Group from Sundial Growers for $105 million, the largest sponsor-driven European cannabis deal and largest 2020 M&A in European horticulture. The deal expands Artemis's portfolio and positions Bridge Farm as a low-cost UK cannabis cultivation platform with over 2 million square feet of automated glasshouse production.The GuardianUK cannabis firm bought by US-based fund in multimillion pound dealBridge Farm, a UK cannabis producer, was acquired by US private equity fund Artemis Growth Partners for about $81m (£66m). The deal could accelerate UK cannabis legalisation, as Artemis expects post-pandemic government pressures to make it taxable. The company holds a Home Office licence to produce and export cannabis to countries like Canada.FinSMEsNobl Closes £1.25M Series A Funding RoundNobl, a London-based cannabis data and consulting firm, closed a £1.25 million Series A funding round. Backers include Altitude Investment Management, Artemis Growth Partners, and Enexis AB. The company will use the funds to expand operations and business reach.PR NewswireNOBL Closes Series A Funding Round at DavosNOBL, a global cannabis data, conferences and consulting company, has closed its Series A funding round with a £1.25 million capital injection from leading cannabis investors. The round attracted participation from Altitude Investment Management, Artemis Growth Partners, and Enexis AB, who cited NOBL's performance and reputation in global markets as justification for the investment. The company stated it will use the funds to invest in talent and innovation while enabling its operating companies to make smarter business decisions in the global cannabis industry.